Main Article Content

Neelum Shahzadi
Dua Fatima Sajid
Muhammad Haseeb-Ur-Rehman
Syeda Tehreem Hussain


Bitter gourd, Momordica charantia, diabetes, bioactive component, antioxidants.


Bitter gourd is an important vegetable which has been used to control blood glucose levels. It possesses a unique set of biologically active components such as charantin, vicine and polypeptide-p that exhibit anti-oxidative and hypoglycaemic potential. Since time immemorial, herbal plants and home-grown plants have been used as a source of alternative medicines; Momordica charantia (bitter gourd) is one of them which are generally used for medicinal purposes in many countries of the world, especially in the subcontinent.

In this research, bitter gourd has been used in raw, crushed and powdered form to perform the chemical and physical analysis in which the researchers determined its moisture and ash content, crude fat, fiber and protein, nitrogen free extract (NFE) along-with the determination minerals. These experiments were done with different methods using different apparatuses. Afterwards, Momordica charantia was made into a supplement form and added in four chapattis with different concentrations to determine its effect on diabetic rats. Before experimenting, the sensory (texture, color and taste) evaluation of the chapattis was also performed.

This study confirms the significance of Momordica charantia powder in regulating sugar levels, highlighting its high nitrogen-free extract, protein, and fiber content. Moreover, the bitter gourd demonstrated higher quantities of calcium, iron, copper, and zinc compared to other minerals. Incorporating Momordica charantia into daily dietary habits can effectively lower both fasting and random blood glucose levels, showcasing its positive impact on blood sugar regulation.

Abstract 626 | PDF Downloads 179


1. Mikstas, C. 2020, Bitter gourd: health benefits, nutrition, and uses. WebMD.
2. Center for Aquatic and Invasive Plants. 2023. | Center for Aquatic and Invasive Plants | University of Florida, IFAS.
3. Mirani, B.N., S.A. Sheikh, S.M. Nizamani, M.J. Channa and A.A. Panhwar. 2012. The effectiveness of traditional food processing on bitter gourd peel. . J. Biol. Life Sci. 3:5-12.
4. Saeed, F., Afzaal, M., Niaz, B., Arshad, M. U., Tufail, T., Hussain, M. B., & Javed, A. 2018. Bitter melon (Momordica charantia): a natural healthy vegetable. International Journal of Food Properties, 21(1), 1270–1290.
5. Tan, E. S. 2019. Antioxidant and Anti-diabetic Properties of Bitter Gourd (Momordica charantia) Fruit. © 2012-2019 International Journal of Sciences: Basic and Applied Research (IJSBAR). 48(5), 76–85.
6. Khandelwal, M. 2022. 'Karela (Bitter Gourd) - Overview, history, uses, benefits, precaution, dosage,' Bhumija Lifesciences [Preprint].
7. Gayathry, K.S. and John, J.A., 2022. A comprehensive review on bitter gourd (Momordica charantia L.) as a gold mine of functional bioactive components for therapeutic foods. Food Production, Processing and Nutrition. 4(1): 1-14.
8. Joseph, B. and D. Jini. 2013. Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency. Asian Pacif. J. Tropic. Dis. 3:93-102.
9. Alam, M.A., R. Uddin, N. Subhan, M.M. Rahman, P. Jain and H.M. Reza. 2015. Beneficial role of bitter melon supplementation in obesity and related complications in metabolic syndrome. J. lip. 2015:1-18.
10. Farooq, M., Abutaha, N., Nasr, F. A., Alqahtani, A. S., Noman, O. M., & Wadaan, M. A. (2019). Bitter gourd (Momordica charantia) possesses developmental toxicity as revealed by screening the seeds and fruit extracts in zebrafish embryos. BMC Complementary and Alternative Medicine, 19(1).
11. Nichols, H. What are the differences between type 1 and type-2 diabetes? 2023. 1-23
12. Anilakumar, K.R., G.P. Kumar and N. Ilaiyaraja. 2015. Nutritional, Pharmacological and Medicinal properties of Momordica charantia. Int. J. Food Sci. Nutr. 4:75-83.
13. Professional, C.C.M. and Cleveland Clinic Medical. 2023. Diabetes.
14. Najm, W. I. (2012). An overview on nutraceuticals and herbal supplements for diabetes and metabolic syndrome. In Elsevier eBooks (pp. 355–365).
15. Wang, Q. et al. 2019. 'Comparison of antidiabetic effects of saponins and polysaccharides from Momordica charantia L. in STZ-induced type 2 diabetic mice,' Biomedicine & Pharmacotherapy, 109, pp. 744–750.
16. Jiang, S. et al. 2020. 'Antidiabetic effect of Momordica charantia saponins in rats induced by high-fat diet combined with STZ,' Electronic Journal of Biotechnology, 43, pp. 41–47
17. Hossain, P., B. Kawar and M.E. Nahas. 2007. Obesity and diabetes in the developing world-A growing challenge. J. Med. 356:213-215.
18. Mahwish et al. 2021. 'Bitter Melon (Momordica charantia L.) Fruit Bioactives Charantin and Vicine Potential for Diabetes Prophylaxis and Treatment,' Plants, 10(4), p. 730.
19. Rauniyar, G.P. et al. 2021 'Effects of Momordica Charantia (Karela/bitterguord) in Type 2 Diabetic Patients Taking Allopathic Drugs: A pilot study,' Kathmandu University Medical Journal, 19(2), pp. 243–247.
20. He, G. et al. 2019. 'Fermented Momordica charantia L. juice modulates hyperglycemia, lipid profile, and gut microbiota in type 2 diabetic rats,' Food Research International, 121, pp. 367–378.